- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06640088
Determining ICU Staffs Conceptions, Opinions, Views, Experiences and Reflection of Brain Death and Organ Donation (DISCOVER)
June 15, 2026 updated by: University Hospital, Basel, Switzerland
The study aims to gather information regarding the individual perceptions, opinions, beliefs, and conceptual understanding of healthcare professionals working in the intensive care units at the University Hospital Basel, the Cantonal Hospital Aarau and the Cantonal Hospital Baselland, and to determine associations of individual beliefs, personal, educational, and professional experiences with individual perceptions, opinions, and conceptual understanding regarding brain death and organ donation.
Study Overview
Status
Completed
Conditions
Detailed Description
To achieve the study objectives, the investigator will employ a questionnaire-based survey administered to the consenting/participating nurses and physicians.
The questionnaire will address various aspects related to personal background, religious affiliation, beliefs about life after death, the conceptual understanding of brain death and organ donation, as well as experiences and opinions related to these topics.
Study Type
Observational
Enrollment (Actual)
338
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Basel, Switzerland, 4031
- University Hospital Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Eligible healthcare professionals in the ICU at the University Hospital Basel, the Cantonal Hospital Aarau and the Cantonal Hospital Baselland
Description
Inclusion Criteria:
- Consenting nurses and physicians currently working in the intensive care units (ICU) at the University Hospital Basel, the Cantonal Hospital Aarau and the Cantonal Hospital Baselland
- Only nurses and physicians consenting to participate will be included
Exclusion Criteria:
- Nurses and physicians not currently working (any more) in the intensive care unit (ICU) at the University Hospital Basel, the Cantonal Hospital Aarau or the Cantonal Hospital Baselland
- Nurses and physicians who do not consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Information on individual perceptions regarding brain death and organ donation
Time Frame: at baseline
|
Descriptive analyses will be performed to identify individual perceptions
|
at baseline
|
|
Information on individual opinions regarding brain death and organ donation
Time Frame: at baseline
|
Descriptive analyses will be performed to identify individual opinions
|
at baseline
|
|
Information on individual beliefs regarding brain death and organ donation
Time Frame: at baseline
|
Descriptive analyses will be performed to identify individual beliefs
|
at baseline
|
|
Information on conceptual understanding regarding brain death and organ donation
Time Frame: at baseline
|
Descriptive analyses will be performed to identify conceptual understanding
|
at baseline
|
|
Identification of interprofessional variations
Time Frame: at baseline
|
Descriptive analyses will be performed to identify interprofessional variations
|
at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raoul C. Sutter, Prof. Dr., University Hospital, Basel, Switzerland
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 14, 2024
Primary Completion (Actual)
April 30, 2025
Study Completion (Actual)
April 30, 2025
Study Registration Dates
First Submitted
October 10, 2024
First Submitted That Met QC Criteria
October 10, 2024
First Posted (Actual)
October 15, 2024
Study Record Updates
Last Update Posted (Actual)
June 17, 2026
Last Update Submitted That Met QC Criteria
June 15, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Req-2024-01116, am24Sutter
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.